Kreos Capital
Kreos Capital is a London-based growth debt firm, founded in 1998 and acquired by BlackRock in 2023, providing venture and growth-stage financing to technology and healthcare companies across 22 countries in Europe and Israel, with €7.0B+ committed across 830+ transactions.
- Company typePrivate
- Founded1998
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Kreos Capital does
Kreos Capital is a London-headquartered growth debt firm founded in 1998, providing venture and growth-stage financing solutions to technology and healthcare companies across Europe and Israel. Since inception it has committed over €7.0 billion across more than 830 transactions to 640+ portfolio companies, deploying capital through eight successive funds. The firm currently invests €800M+ per year across 22 countries, with a relationship-driven origination model anchored by seven managing partners and approximately 50 employees. Its portfolio spans enterprise software, fintech, cybersecurity, deeptech and quantum computing, life sciences, and digital consumer businesses, with named borrowers including Lapse, Soldo, TrustLayer, IQM, Bit.Bio, Ori Biotech, Xyte AI, Syte, and Cosmose AI.
The business model is classic growth debt fund management: Kreos raises dedicated funds from institutional LPs (now consolidated under BlackRock ownership following the August 2023 acquisition), charges management fees on committed and invested capital, and earns carried interest on realized gains above hurdle rates. Deal structuring spans senior term loans, unitranche facilities, growth capital, and follow-on equity co-investments, with typical ticket sizes supporting venture-to-growth-stage transitions. Underwriting is relationship-driven, leveraging partner networks built over 27 years and supplemented by BlackRock's broader capital markets and balance-sheet capabilities post-acquisition.
The August 2023 BlackRock acquisition transformed Kreos from an independent specialist into a wholly-owned subsidiary within a global asset manager exceeding $10 trillion in AUM. This integration materially expanded Kreos's cost-of-capital advantage, fundraising reach, and ability to underwrite larger and more structured transactions, while preserving its brand, partner team, and European growth-debt franchise. Strategic priorities under BlackRock ownership include scaling deployment toward and beyond €1B annually, deepening vertical coverage in deeptech and healthcare, and leveraging the parent platform for capital markets, structured solutions, and cross-fund co-investment.
Kreos Capital firmographics
Firmographics- Name
- Kreos Capital
- Legal name
- Kreos Capital
- Website
- https://kreoscapital.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Kreos Capital is a London-based growth debt firm, founded in 1998 and acquired by BlackRock in 2023, providing venture and growth-stage financing to technology and healthcare companies across 22 countries in Europe and Israel, with €7.0B+ committed across 830+ transactions.
- Ownership category
- akta.pro rank
Kreos Capital industry classification
Industry- Product category
- Venture Debt / Growth Debt Financing
- NAICS
- Other Financial Investment Activities (5239)
- SIC
- Miscellaneous Business Credit Institution (6159)
- akta.pro primary industry
- Venture Growth / Recurring Revenue Credit Funds (FSANAIAG)
- akta.pro secondary industry
- SME Term Loans & Growth Capital (FSAKAGAB)
Keywords
Where Kreos Capital is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Kreos Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
Revenue model
- Growth Debt Financing: Kreos Capital provides debt facilities to high-growth companies, generating returns through interest income and warrant participation. They serve as a long-term finance partner providing financing across multiple business cycles for companies in technology and healthcare sectors.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Kreos Capital product offering
Product offeringCore offering
Kreos Capital provides growth debt financing to high-growth technology and healthcare companies across Europe and Israel. The firm offers tailored debt facilities spanning entry-level growth, mid-stage, late-stage, pre-IPO/exit, and publicly listed growth funding stages. Returns are generated through interest income and warrant participation as a long-term finance partner to portfolio companies and equity sponsors.
Product overview
Kreos Capital is a growth debt provider offering financing solutions for high-growth companies in the technology and healthcare sectors across Europe and Israel. The company does not operate as a traditional product/software company but rather as a financial services firm providing debt financing at various stages of company growth, from entry-level growth and mid-stage development through to late stage, pre-IPO/exit funding, and publicly listed growth funding. Their financing products serve as an alternative or complement to equity capital for portfolio companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Growth Debt Financing Tailored debt facilities provided to high-growth technology and healthcare companies across Europe and Israel, spanning entry-level growth, mid-stage, late-stage, pre-IPO/exit, and publicly listed growth funding. Generates returns through interest income and warrant participation as a long-term finance partner.
Companies that use Kreos Capital
Customer profileNamed customers15 records
Segments2 records
Ideal customer profiles2 records
Kreos Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Kreos Capital partnerships and signals
Strategic signalScale indicators8 records
Recent moves6 records
Expansion highlights5 records
Kreos Capital competitors and assessment
Company assessmentDirect peers
- Triple Point Capital: UK-based venture debt provider focused on growth-stage technology and life sciences companies in Europe. Closely comparable to Kreos on geography, sector focus, and stage of lending.
- Hercules Capital: US-listed specialty finance company providing venture debt to high-growth technology and healthcare companies. Comparable to Kreos in product, sector focus, and borrower profile, though primarily US-focused.
- Horizon Technology Finance: US-listed venture debt platform lending against the assets of venture-backed technology, life science, and healthcare companies. Closely mirrors Kreos's growth-debt model and sector specialization.
- Runway Growth Capital: US-focused venture debt provider offering growth loans to late-stage companies across technology and life sciences. Operates a similar growth-debt product to Kreos with comparable borrower profile.
- Trinity Capital: US-listed specialty finance company providing venture debt and equipment financing to growth-stage technology and healthcare companies. Highly comparable business model to Kreos.
Regional players
- CommerzVentures: European venture debt and growth equity arm of Commerzbank, focused on fintech and B2B software companies. Comparable to Kreos's European tech focus but concentrated in DACH and France.
Broad incumbents
- Muzinich & Co: Global private credit asset manager with European private debt strategies across direct lending and special situations. Broader incumbent competing for institutional private credit mandates relevant to Kreos's strategy.
- Arcmont Asset Management: European private credit manager (formerly Bridgepoint Credit) providing direct lending and asset-backed financing across the capital structure. Overlaps with Kreos on mid-market European lending.
- Hayfin Capital Management: European alternative credit manager with direct lending and special situations funds. Comparable European private credit platform that can compete with Kreos for institutional capital and deal flow.
- Permira Credit: European private credit arm of Permira offering direct lending and special situations strategies. Competes with Kreos for European mid-market and growth-stage lending opportunities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Kreos Capital social profiles
Digital presenceKreos Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kreos Capital leadership team
Management profileNumber of profiles
Profiles8 records
Kreos Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kreos Capital M&A and investment
M&A and investmentM&A
Investments147 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kreos Capital
What does Kreos Capital do?
Kreos Capital provides growth debt financing to high-growth technology and healthcare companies across Europe and Israel. The firm offers tailored debt facilities spanning entry-level growth, mid-stage, late-stage, pre-IPO/exit, and publicly listed growth funding stages. Returns are generated through interest income and warrant participation as a long-term finance partner to portfolio companies and equity sponsors.
Is Kreos Capital a public or private company?
Kreos Capital is a private company. It is classified as corporate owned and is currently operating.
When was Kreos Capital founded?
Kreos Capital was founded in 1998. It employs 11 to 50 people.
Where is Kreos Capital based?
Kreos Capital is headquartered in London, United Kingdom, in the Europe region.
How does Kreos Capital make money?
One revenue line is on record: growth Debt Financing.
Who are Kreos Capital's main competitors?
Direct peers on record are Triple Point Capital, Hercules Capital, Horizon Technology Finance, Runway Growth Capital and Trinity Capital. CommerzVentures is listed as a regional player. Broad incumbents are Muzinich & Co, Arcmont Asset Management, Hayfin Capital Management and Permira Credit.
Does Kreos Capital have an API?
No public API is recorded for Kreos Capital.
What industry is Kreos Capital in?
Kreos Capital's product category is Venture Debt / Growth Debt Financing. Its primary akta.pro industry code is FSANAIAG, Venture Growth / Recurring Revenue Credit Funds, with a secondary code of FSAKAGAB, SME Term Loans & Growth Capital. Its NAICS code is 5239 and its SIC code is 6159.